RV
Resverlogix Corp.
RVXCF · OTC
$0.06 +5.81% (+$0.00)
1M -7.62%
Market Cap $19.0M
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 33.65%
Asset turnover 0.00x
ROA 127.08%
Debt
0 /100
High Current ratio 0.04x
Int. coverage -0.45x
Debt/Equity N/A
Stability
81 /100
Stable Beta 1.06x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RVXCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Donald J. McCaffrey
Employees
19
Headquarters
Calgary
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report